Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Three new cancer treatments are to be made available on the NHS in Scotland, as six drugs are given the green light for use.

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

The Obafemi Awolowo University Teaching Hospital Complex (OAUTHC), Ile-Ife, performed 55 cancer surgeries in January, according to Prof. Segun Alatise, a professor of surgery in the hospital’s ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

H.C. Wainwright analyst Andres Y. Maldonado confirmed a Buy rating and a $75.00 price target on Corbus Pharmaceuticals (NASDAQ:CRBP), representing significant upside potential from the current price ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

Marla Anderson, MD, a board-certified surgeon, shares practical advice for living with metastatic breast cancer and tips for ...

Kathleen Daly, MD, a board-certified psychiatrist, shares self-care strategies for people living with metastatic breast cancer. She sheds light on common fears she's observed among her patients and ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...